Text Size
30 studies found for:    " May 31, 2009":" June 30, 2009"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]

Modify this search | How to Use Search Results

Show Display Options
RSS Create an RSS feed from your search for:
" May 31, 2009":" June 30, 2009"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Hepatitis B Virus (HBV) Prevention for Homeless at Risk for HBV/Hepatitis C Virus (HCV)/HIV
Conditions: Hepatitis B;   Hepatitis C;   HIV;   HIV Infections
Interventions: Behavioral: NCMIT;   Behavioral: SCMIT
2 Active, not recruiting Treatment of Acute HIV With Emtricitabine, Tenofovir and Efavirenz (CID 0805)
Conditions: Acute HIV Infection;   HIV Infections
Intervention: Drug: Atripla
3 Active, not recruiting HIV Viral Load Monitoring in Resource-Poor Settings
Conditions: HIV;   AIDS;   HIV Infections
Intervention: Other: HIV-1 viral load testing
4 Recruiting Evaluation of Three Strategies of Second-line Antiretroviral Treatment in Africa (Dakar - Bobo-Dioulasso - Yaoundé)
Conditions: HIV;   HIV Infections
Interventions: Drug: emtricitabine/tenofovir + lopinavir/ritonavir (WHO recommended second line);   Drug: abacavir + didanosine + lopinavir/ritonavir (WHO recommended second line);   Drug: emtricitabine/tenofovir + darunavir + ritonavir (Second line strategy under evaluation)
5 Completed Effect of Extra Virgin Olive Oil on Atherosclerosis Biomarkers in HIV-infected Patients
Conditions: HIV;   Atherosclerosis;   HIV Infections
Interventions: Other: consumption 1. EVOO; 2. ROO;   Other: consumption 1. ROO; 2. EVOO
6 Completed An Expanded Safety Study of Dapivirine Gel 4789 in Africa
Conditions: HIV Infections;   Acquired Immunodeficiency Syndrome;   Healthy
Interventions: Drug: dapivirine;   Drug: placebo
7 Completed An Expanded Safety Study of Dapivirine Gel 4759 in Africa
Conditions: HIV Infections;   Acquired Immunodeficiency Syndrome
Interventions: Drug: dapivirine;   Drug: placebo
8 Active, not recruiting Effect of Bednets and a Water Purification Device on HIV Disease Progression Among ART naïve Patients in Kenya
Conditions: HIV Infections;   Human Immunodeficiency Virus;   Malaria;   Plasmodium Falciparum;   Diarrhea
Intervention: Other: Bednets and Water Purification
9 Completed Anal Cancer Screening Study
Conditions: HIV Infections;   Papillomavirus Infections;   Anus Neoplasms
Intervention:
10 Active, not recruiting Natural History Study of HIV Acquired in Infancy or Childhood
Condition: HIV Infections
Intervention:
11 Completed Evaluation of Cardiovascular Effects of Smoking Cessation in HIV Patients
Conditions: HIV Infections;   Smokers
Intervention:
12 Recruiting Safety and Immune Response Assessment Study of Killed-whole HIV-1 Vaccine (SAV001-H) in Chronic HIV-1 Infected Patients
Condition: HIV Infections
Intervention: Biological: SAV001-H
13 Active, not recruiting CCR5 Inhibitor Treatment Intensification on CD4+ T-cell Recovery
Condition: HIV Infections
Intervention: Drug: Maraviroc
14 Completed Integration of HIV Care and Treatment Into Antenatal Care in Migori District, Kenya
Condition: HIV Infections
Intervention: Procedure: Integrated ANC, PMTCT, HIV services
15 Completed A Pilot Study of Pre-Exposure Prophylaxis (PrEP) to Evaluate Safety, Acceptability, and Adherence in At-risk Populations in Uganda, Africa
Condition: HIV Infection
Interventions: Drug: FTC/TDF;   Drug: Placebo
16 Suspended Cognitive Rehabilitation in Ugandan Children With HIV
Condition: HIV Infections
Interventions: Behavioral: Computerized cognitive rehabilitation therapy (CCRT);   Behavioral: control group
17 Completed A Study of Anti-HIV Monoclonal Antibody KD-247
Condition: HIV Infections
Interventions: Drug: KD-247;   Drug: Physiological saline
18 Completed Antiretroviral-Sparing Concept With HIV-specific T Cell Precursors With High Proliferative Capacity (PHPC)
Condition: HIV Infection
Interventions: Biological: DermaVir;   Biological: Placebo;   Drug: HAART
19 Unknown † TMC114-TiDP29-C228 - A Safety Study to Evaluate the Antiviral Activity of Darunavir (DRV) in Combination With Ritonavir (Rtv) in HIV 1 Infected Children From 3 Years to Below 6 Years of Age
Condition: HIV Infections
Interventions: Drug: liquid ritonavir;   Drug: Darunavir tablets;   Drug: Darunavir suspension
20 Active, not recruiting Efficacy and Safety of Varenicline Among HIV-infected Patients
Conditions: HIV Infections;   Tobacco Dependence
Interventions: Drug: Varenicline;   Drug: Placebo
To Top

Previous Page Studies Shown (1-20) Next Page (21-30) Show next page of results
† Indicates status has not been verified in more than two years